Omeprazole

Product NDC: 68071-2262
Requested package NDC: 68071-2262-3
11-digit product format: 680712262
Labeler code: 68071
Product ID: 68071-2262_4cc4b32a-0daf-e922-e063-6294a90ab8cd
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Omeprazole
Dosage form: CAPSULE, DELAYED RELEASE
Route: ORAL
Labeler: NuCare Pharmaceuticals,Inc.
Application: ANDA203270
Marketing category: ANDA
Marketing start: 2015-08-19
Substance: OMEPRAZOLE
Active strength: 20 mg/1
Pharmacologic classes: Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A203270-001	OMEPRAZOLE	OMEPRAZOLE	10MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2015-08-19
A203270-002	OMEPRAZOLE	OMEPRAZOLE	20MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2015-08-19
A203270-003	OMEPRAZOLE	OMEPRAZOLE	40MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2015-08-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A203270-001	AB
A203270-002	AB
A203270-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A203270-001	OMEPRAZOLE	10MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2015-08-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A203270-002	OMEPRAZOLE	20MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2015-08-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A203270-003	OMEPRAZOLE	40MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2015-08-19	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A203270-001	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A203270-002	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A203270-003	AB	1	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 17 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Omeprazole	OMEPRAZOLE	QPharma Inc	50115204-74f7-17c1-e063-6394a90ab665	2026-06-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	Preferred Phharmaceuticals Inc.	319d990e-161b-4c16-b026-f55c413c7e8f	2026-04-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	Proficient Rx LP	61eab342-61fd-471f-8f70-95f9cbca0097	2026-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	A-S Medication Solutions	c1276463-7357-45b5-9f7e-8d3c4a550ff4	2026-03-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	A-S Medication Solutions	df1a4294-3893-4a11-b4d5-f3536678087e	2026-03-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	NuCare Pharmaceuticals,Inc.	af707c0a-5193-3f83-e053-2995a90a78ef	2026-03-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270 ndc (package): 68071-2262-3 ndc (product): 68071-2262 ndc11 (package): 68071226203
Omeprazole	OMEPRAZOLE	Northwind Health Company, LLC	10a3fbc9-00c6-ad83-e063-6294a90ae1ad	2026-01-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	Northwind Health Company, LLC	f3038133-8bb2-044e-e053-2995a90a6e7d	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	QPharma, Inc.	f5dd5d63-1376-1ff7-e053-2a95a90a1d94	2025-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	Bryant Ranch Prepack	40b4e1b6-f64d-44d5-bfc2-0cb8f78d9e67	2025-08-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	Bryant Ranch Prepack	064b1418-0f42-4b18-9dee-cda40c5e1fca	2024-12-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	Bryant Ranch Prepack	c311c1b9-8ec2-4ac0-baa2-a5063fba2d80	2024-12-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	Rising Pharma Holdings, Inc.	a1b1c61b-d4fe-433d-ad31-0b11758976fa	2024-11-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	A-S Medication Solutions	fe7d3352-d53f-4046-92ed-1eb5c917fbee	2024-08-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	A-S Medication Solutions	8d925ca6-83f1-4263-8218-4bf7cc8ceb39	2024-08-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	A-S Medication Solutions	9378c870-f2cc-4a60-b0fd-08a4d43857bc	2024-08-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270
Omeprazole	OMEPRAZOLE	Aurobindo Pharma Limited	934601b6-fbba-43c4-a8ef-7a7dfe9f9a51	2024-06-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203270 application number: ANDA203270

Additional Listing Data#

Finished product: Yes
Brand name base: Omeprazole
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
OMEPRAZOLE	20 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
KG60484QX9	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
198051	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
af707c0a-5193-3f83-e053-2995a90a78ef	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
873ef493-6b37-49d8-ac7f-bfca4117d2c1	Product name	5	20210607
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
f33561b9-47cb-411c-a228-16c62e346cd4	Product name	1	20200415
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68071-2262-3	Omeprazole	30 in 1 BOTTLE	CAPSULE, DELAYED RELEASE	30		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68071-2262	OMEPRAZOLE CAPSULE, DELAYED RELEASE [NUCARE PHARMACEUTICALS,INC.]	3	Current NDC, Legacy NDC, 1 package rows	20240719_af707c0a-5193-3f83-e053-2995a90a78ef.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
KG60484QX9	OMEPRAZOLE	73590-58-6	OMEPRAZOLE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198051	omeprazole 20 MG Delayed Release Oral Capsule	PSN	af707c0a-5193-3f83-e053-2995a90a78ef	4
198051	omeprazole 20 MG Delayed Release Oral Capsule	SCD	af707c0a-5193-3f83-e053-2995a90a78ef	4
198051	omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral Capsule	SY	af707c0a-5193-3f83-e053-2995a90a78ef	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
68071-2262-3	68071226203	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68071-2262-3)	2020-09-16	0000-00-00	No	No	Current